Article Details

Recro Pharma Inc. (NASDAQ: REPH) Forecast To Gain 54.55% And Reach Consensus Price Target

Retrieved on: 2021-08-16 12:33:37

Tags for this article:

Click the tags to see associated articles and topics

Recro Pharma Inc. (NASDAQ: REPH) Forecast To Gain 54.55% And Reach Consensus Price Target. View article details on hiswai:

Excerpt

The top two institutional holders are Renaissance Technologies, LLC with over 1.38 million shares worth more than $3.93 million. As of Dec 30, 2020, ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up